NASDAQ:ABUS - Arbutus Biopharma Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$11.55 +0.15 (+1.32 %)
(As of 07/20/2018 02:13 PM ET)
Previous Close$11.50
Today's Range$11.45 - $11.95
52-Week Range$3.20 - $12.05
Volume15,406 shs
Average Volume833,219 shs
Market Capitalization$623.40 million
P/E Ratio-6.37
Dividend YieldN/A

Analyst Ratings

Arbutus Biopharma (NASDAQ:ABUS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Arbutus Biopharma in the last 12 months. Their average twelve-month price target is $8.80, suggesting that the stock has a possible downside of 23.81%. The high price target for ABUS is $13.00 and the low price target for ABUS is $5.00. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldBuyBuyBuy
Consensus Rating Score: 2.402.602.672.83
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $8.80$8.40$12.3750$12.50
Price Target Upside: 23.81% downside39.53% upside135.71% upside140.38% upside

Arbutus Biopharma (NASDAQ:ABUS) Consensus Price Target History

Price Target History for Arbutus Biopharma (NASDAQ:ABUS)

Arbutus Biopharma (NASDAQ:ABUS) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/16/2018Chardan CapitalReiterated RatingBuy$11.00HighView Rating Details
7/6/2018B. RileyDowngradeBuy ➝ Neutral$9.00 ➝ $9.00HighView Rating Details
3/19/2018WedbushDowngradeOutperform ➝ Neutral$9.00 ➝ $6.00MediumView Rating Details
11/7/2017Leerink SwannReiterated RatingMarket Perform$4.00 ➝ $5.00N/AView Rating Details
10/4/2017JMP SecuritiesReiterated RatingOutperform$12.00 ➝ $13.00HighView Rating Details
6/2/2017LADENBURG THALM/SH SHInitiated CoverageBuy$32.00LowView Rating Details
1/9/2017Bloom BurtonUpgradeAccumulate ➝ BuyN/AView Rating Details
8/21/2016William BlairReiterated RatingOutperformN/AView Rating Details
(Data available from 7/20/2016 forward)
This page was last updated on 7/20/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.